Newsroom

Sorted by: Latest

-

Lovell Minnick Portfolio Company Xactus Acquires Mortgage Credit Link

PHILADELPHIA & NEW YORK--(BUSINESS WIRE)--Lovell Minnick Partners (“Lovell Minnick”), a private equity firm focused on investments in financial services, business services, and related technology companies, today announced that its portfolio company, Xactus®, completed the acquisition of Mortgage Credit Link™ (MCL), a web-based order fulfillment hub that streamlines credit and verification data ordering from application to closing. This strategic addition will operate as XedaLink™, an independe...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 26.05.2026 FPX. IE00BYTH6238 200,002.00 USD 14,388,925.01 71.944  ...
-

Aeonsemi 推出第二代 ChronoPHY™ 10GBASE-T PHY 強化 AI 邊緣確定性乙太網基礎設施

美國加州聖塔克拉拉--(BUSINESS WIRE)--(美國商業資訊)-- 專注於混合訊號與 DSP 連線 IC 之創新廠商 Aeonsemi(www.aeonsemi.com)今日宣布,旗下 ChronoPHY™ 多速率 10GBASE-T 乙太網路收發器家族第二代產品 AS22010 正式進入量產出貨。AS22010 相較前一代產品典型功耗降低 40%,同時強化連線穩定性、電磁干擾(EMI)耐受度與網路同步精準度,可達 ITU‑T G.8273.2 Class D 時脈效能等級。 ChronoPHY™ 是 Aeonsemi 為時間敏感網路(TSN) 應用所最佳化之乙太網路 PHY 架構,具備低抖動、低延遲特性,適用於無線基礎設施、AI 邊緣、工業自動化與即時乙太網路系統。 Aeonsemi 執行長黃雲騰表示:「AI 應用正推動高速乙太網路從資料中心延伸至邊緣端,低功耗、精準同步與穩定時序能力,正成為新一代網路基礎設施的重要關鍵。AS22010 延續 ChronoPHY™ 領先優勢,帶來更精準的同步能力、更穩健的連線品質,以及更佳能效表現。」 機器人、機器視覺與 AI 工業自動化等...
-

Aeonsemi Unveils Second-Generation ChronoPHY™ 10GBASE-T PHY for Deterministic AI Edge Infrastructure

SANTA CLARA, Calif.--(BUSINESS WIRE)--Aeonsemi (www.aeonsemi.com), an innovator of mixed-signal and DSP connectivity ICs, today announced production shipments of AS22010, the second generation of its ChronoPHY™ multi-rate 10GBASE-T Ethernet transceiver family. The AS22010 reduces typical per-port power by 40% compared to the previous generation while simultaneously improving link stability, electromagnetic interference (EMI) immunity, and synchronization accuracy to support ITU-T G.8273.2 Class...
-

Harmony Biosciences to Participate in Upcoming Investor Conferences

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conferences. Goldman Sachs 47th Annual Global Healthcare Conference Fireside Chat: June 9, 2026, at 8:40 a.m. ET Location: Miami, FL Oppenheimer CNS & Neuro-Muscular Summit Fireside Chat: June 10, 2026, at 3:25 p.m. ET Location: Miami, FL A webcast of the fireside chats will be available on the investor...
-

Stem Brings PowerTrack EMS to Latin America’s Utility-Scale Hybrid Market with Granja Solar Project in Chile

HOUSTON--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced that Copec Flux, the renewable energy subsidiary of Copec S.A., is deploying Stem’s PowerTrack™ Energy Management System (EMS) at the Granja Solar project in Chile. This development expands Stem’s Latin America footprint and represents a meaningful step into the region’s utility-scale hybrid market. The Granja project is an existing 135 MW PV project that Copec is...
-

Intellicheck To Present at the Planet Microcap Showcase in Las Vegas

MELVILLE, N.Y.--(BUSINESS WIRE)--Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company delivering proprietary on-demand digital and physical identity validation solutions, today announced that CEO Bryan Lewis will present at the Planet Microcap Showcase 2026 taking place on Wednesday, June 17, 2026 at the Bellagio Hotel & Resort in Las Vegas, Nevada. Joining him at the conference will be CFO Adam Sragovicz. The presentation will begin at 3:00 p.m. PT on Wednesday, June 17....
-

Turn Therapeutics Announces Peer-Reviewed Publication in Journal of Dermatological Treatment Highlighting GX-03 Activity in IL-36 Associated Inflammatory Model

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company focused on developing localized therapies for inflammatory and infectious skin diseases, today announced the publication of a peer-reviewed research article in the Journal of Dermatological Treatment evaluating the effects of its lead program, GX-03, in an IL-36–associated inflammatory environment. The publication, titled “Effects of extended-release topical polyhexanide in a...
-

Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference...
-

Futurum Group Enters Definitive Agreement to Acquire Aptiviti Inc., Parent of Enterprise Technology Research (ETR), Bringing Wall Street’s Premier Predictive Data into its Futurum Intelligence Platform™

AUSTIN, Texas--(BUSINESS WIRE)--The acquisition integrates Aptiviti’s ETR institutional-grade spending data into Futurum Intelligence Platform™ enhancing the range of intelligence...